40 Speen Street, Suite 102
Framingham, Massachusetts 01701
August 19, 2021
Securities and Exchange Commission
Division of Corporation Finance
Office of Life Sciences
100 F Street, N.E.
Washington, D.C. 20549
Attention: Jeffrey Gabor
Re: Xenetic Biosciences, Inc. Registration Statement on Form S-3 (File No. 333-258810)
Ladies and Gentlemen:
Pursuant to Rule 461 of the General Rules and Regulations promulgated under the Securities Act of 1933, as amended, Xenetic Biosciences, Inc. hereby requests that its Registration Statement on Form S-3 (File No. 333-258810) filed with the Securities and Exchange Commission (the “Commission”) on August 13, 2021 be declared effective by the Commission at 5:00 p.m. Eastern Time on Monday, August 23, 2021, or as soon thereafter as practical.
Once the Registration Statement is declared effective, please orally confirm that event with our counsel, Holland & Knight LLP, by calling Danielle Price at (305) 349-2259.
Thank you for your assistance.
|/s/ James Parslow|
|Chief Financial Officer|